Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles C Mundorff

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Molecular & Cellular Proteomics : MCP|October 9, 2025
Mapping Hydrogen Migration Thresholds for Site-Specific HDX-MSCharles C Mundorff, Sarah Hadley, Lisa M Tuttle, et al.
Molecular & Cellular Proteomics : MCP|March 14, 2022
TAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery DiseaseBryan T MacDonald, Hasmik Keshishian, Charles C Mundorff, et al.
The Journal of Experimental Medicine|August 29, 2022
Correction: IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2Malika Hale, Jason Netland, Yu Chen, et al.
The Journal of Experimental Medicine|August 8, 2022
IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2Malika Hale, Jason Netland, Yu Chen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Molecular & Cellular Proteomics : MCP|October 9, 2025
Mapping Hydrogen Migration Thresholds for Site-Specific HDX-MSCharles C Mundorff, Sarah Hadley, Lisa M Tuttle, et al.
Molecular & Cellular Proteomics : MCP|March 14, 2022
TAILS Identifies Candidate Substrates and Biomarkers of ADAMTS7, a Therapeutic Protease Target in Coronary Artery DiseaseBryan T MacDonald, Hasmik Keshishian, Charles C Mundorff, et al.
The Journal of Experimental Medicine|August 29, 2022
Correction: IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2Malika Hale, Jason Netland, Yu Chen, et al.
The Journal of Experimental Medicine|August 8, 2022
IgM antibodies derived from memory B cells are potent cross-variant neutralizers of SARS-CoV-2Malika Hale, Jason Netland, Yu Chen, et al.
Pageof 1